Literature DB >> 16758358

Nicotine exposure does not alter plasma to brain choline transfer.

Paul R Lockman1, Julie Gaasch, Ghia McAfee, Thomas J Abbruscato, Cornelis J Van der Schyf, David D Allen.   

Abstract

Acute and chronic nicotine exposure in rats is associated with an increase in brain acetylcholine (ACh) transmission. The acquisition of choline for neuronal ACh synthesis occurs primarily via two pathways; first, free choline is transported from the blood across the blood-brain barrier (BBB) and/or second, from synaptic choline generated by either hydrolysis of non-bound ACh or membrane phosphatidylcholine catabolism. To determine if nicotine-induced cholinergic demand is associated with increased choline transport rates into brain, we measured BBB choline transport in naïve and S-(-) nicotine exposed rats (acute and chronic, 4.5 mg/kg/d for 1, 14, 21 and 28 d; osmotic minipumps) using the in situ rat brain perfusion technique. No significant changes in choline uptake after acute or chronic nicotine exposure were observed in whole brain or cortex. Of considerable interest was a significant decrease in regional brain choline uptake measured in the hippocampus after chronic nicotine exposure (28 d). Our data suggest that the increased ACh transmission observed after nicotine exposure does not correlate with increased blood-to-brain transfer of choline. Considering these data and previous literature reports, we propose that the additional free choline required under conditions of nicotine exposure (for ACh synthesis) is primarily recruited from membrane phospholipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16758358     DOI: 10.1007/s11064-006-9047-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles.

Authors:  Paul R Lockman; Joanna Koziara; Karen E Roder; Jennifer Paulson; Thomas J Abbruscato; Russell J Mumper; David D Allen
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

2.  Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure.

Authors:  P R Lockman; G McAfee; W J Geldenhuys; C J Van der Schyf; T J Abbruscato; D D Allen
Journal:  J Pharmacol Exp Ther       Date:  2005-04-21       Impact factor: 4.030

Review 3.  Signaling through phosphatidylcholine breakdown.

Authors:  J H Exton
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

4.  Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in alpha4 nicotinic receptor subunit knockout mice.

Authors:  R E Ryan; S A Ross; J Drago; R E Loiacono
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum.

Authors:  J C Maire; R J Wurtman
Journal:  J Physiol (Paris)       Date:  1985

6.  Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique.

Authors:  D D Allen; Q R Smith
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

7.  Apoptosis is induced by choline deficiency in fetal brain and in PC12 cells.

Authors:  M Q Holmes-McNary; R Loy; M H Mar; C D Albright; S H Zeisel
Journal:  Brain Res Dev Brain Res       Date:  1997-07-18

8.  Chronic nicotine and withdrawal effects on radial-arm maze performance in rats.

Authors:  E D Levin; C Lee; J E Rose; A Reyes; G Ellison; M Jarvik; E Gritz
Journal:  Behav Neural Biol       Date:  1990-03

9.  Nicotine improves learning and memory in rats: morphological evidence for acetylcholine involvement.

Authors:  Gülay Uzüm; A Sarper Díler; Nesrín Bahçekapili; Mustafa Tasyüreklí; Y Zíya Zíylan
Journal:  Int J Neurosci       Date:  2004-09       Impact factor: 2.292

10.  Nicotine administration to rats: methodological considerations.

Authors:  L C Murrin; J R Ferrer; W Y Zeng; N J Haley
Journal:  Life Sci       Date:  1987-04-27       Impact factor: 5.037

View more
  1 in total

1.  Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD).

Authors:  Linda P Dwoskin; B Matthew Joyce; Guangrong Zheng; Nichole M Neugebauer; Vamshi K Manda; Paul Lockman; Roger L Papke; Michael T Bardo; Peter A Crooks
Journal:  Biochem Pharmacol       Date:  2007-07-21       Impact factor: 5.858

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.